Oleoyl-estrone increases adrenal corticosteroid synthesis gene expression in overweight male rats

Steroids

Volumn 75, Issue 1, 2010, Pages 20-26

  Romero, María del Mar ^a,b   Vilà, Ruth ^a,b   Fernández López, José Antonio ^a,b   Esteve, Montserrat ^a,b   Alemany, Marià ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

Adrenal glands; Corticosterone synthesis; Glucocorticoids; Oleoyl estrone; Overweight; Pair feeding

Indexed keywords

CATECHOLAMINE; CORTICOSTEROID; CORTICOSTERONE; DEHYDROCORTICOSTERONE; ESTRONE DERIVATIVE; ESTRONE OLEATE; STEROID 5ALPHA REDUCTASE; UNCLASSIFIED DRUG;

ADRENAL FUNCTION; ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALORIC INTAKE; CATECHOLAMINE SYNTHESIS; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; FEEDBACK SYSTEM; GENE EXPRESSION; LIVER; MALE; NONHUMAN; OBESITY; ORGAN WEIGHT; RAT; STEROIDOGENESIS; TISSUE LEVEL;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADRENAL CORTEX HORMONES; ADRENAL GLANDS; ANIMALS; BODY WEIGHT; CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME; CORTICOSTERONE; ESTRONE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOCORTICOIDS; LIVER; MALE; MOLECULAR WEIGHT; OLEIC ACIDS; ORGAN SIZE; OVERWEIGHT; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEROID 11-BETA-HYDROXYLASE; STEROID 21-HYDROXYLASE; TESTOSTERONE 5-ALPHA-REDUCTASE;

RATTUS;

EID: 71849112101     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2009.09.009     Document Type: Article

References (60)

1. Hafezi-Moghadam A., Simoncini T., Yang Z.Q., Limbourg F.P., Plumier J.C., Rebsamen M.C., et al. Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med 8 (2002) 473-479
2. Viru A., and Viru M. Cortisol - essential adaptation hormone in exercise. Int J Sports Med 25 (2004) 461-464
3. Ishikawa M., Ohdo S., Watanabe H., Hara C., and Ogawa N. Alteration in circadian-rhythm of plasma-corticosterone in rats following sociopsychological stress-induced by communication box. Physiol Behav 57 (1995) 41-47
4. Epel E.S., Lapidus R., McEwen B., and Brownell K. Stress may add bite to appetite in women: a laboratory study of stress-induced cortisol and eating behavior. Psychoneuroendocrinology 26 (2001) 37-49
5. Huscher D., Thiele K., Gromnica-Ihle E., Hein G., Demary W., Dreher R., et al. Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis (2008) [published online]
6. Vogelzangs N., Suthers K., Ferrucci L., Simonsick E.M., Ble A., Schrager M., et al. Hypercortisolemic depression is associated with the metabolic syndrome in late-life. Psychoneuroendocrinoliogy 32 (2007) 151-159
7. Barnes P.J. How corticosteroids control inflammation: Quintiles prize lecture 2005. Br J Pharmacol 148 (2006) 245-254
8. Schuld A., Birkmann S., Beitinger P., Haack M., Kraus T., Dalal M.A., et al. Low doses of dexamethasone affect immune parameters in the absence of immunological stimulation. Exp Clin Endocrinol Diabetes 114 (2006) 322-328
9. Asensio C., Muzzin P., and Rohner-Jeanrenaud F. Role of glucocorticoids in the physiopathology of excessive fat deposition and insulin resistance. Int J Obes 28 Suppl. 4 (2004) S45-S52
10. Wolf G. Glucocorticoids in adipocytes stimulate visceral obesity. Nutr Rev 60 (2002) 148-151
11. Fujita K., Nishizawa H., Funahashi T., Shimomura I., and Shimabukuro M. Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circul J 70 (2006) 1437-1442
12. Dandona P., Ghanim H., Mohanty P., and Chaudhuri A. The metabolic syndrome: Linking oxidative stress and inflammation to obesity, type 2 diabetes, and the syndrome. Drug Develop Res 67 (2006) 619-626
13. Giugliano D., Ceriello A., and Esposito K. The effects of diet on inflammation emphasis on the metabolic syndrome. J Am Coll Cardiol 48 (2006) 677-685
14. Tilg H., and Moschen A.R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6 (2006) 772-783
15. Maury E., Ehala-Aleksejev K., Guiot Y., Detry R., Vandenhooft A., and Brichard S.M. Adipokines oversecreted by omental adipose tissue in human obesity. Am J Physiol 293 (2007) E656-E665
16. Robinson L.E., and Graham T.E. Metabolic syndrome, a cardiovascular disease risk factor: role of adipocytokines and impact of diet and physical activity. Can J Appl Physiol 29 (2004) 808-829
17. Wei Y.Z., Chen K.M., Whaley-Connell A.T., Stump C.S., Ibdah J.A., and Sowers J.R. Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species. Am J Physiol 294 (2008) R673-R680
18. Alexandraki K., Piperi C., Kalofoutis C., Singh J., Alaveras A., and Kalofoutis A. Inflammatory process in type 2 diabetes The role of cytokines. Ann NY Acad Sci 1084 (2006) 89-117
19. Tokuyama K., and Himms-Hagen J. Adrenalectomy prevents obesity in glutamate-treated mice. Am J Physiol 257 (1989) E139-E144
20. Feldkircher K.M., Mistry A.M., and Romsos D.R. Adrenalectomy reverses pre-existing obesity in adult genetically obese (ob/ob) mice. Int J Obes 20 (1996) 232-235
21. Gemmill M.E., Eskay R.L., Hall N.L., Douglass L.W., and Castonguay T.W. Leptin suppresses food intake and body weight in corticosterone-replaced adrenalectomized rats. J Nutr 133 (2003) 504-509
22. Grasa M.M., Cabot C., Adán C., Vilà R., Esteve M., Estruch J., et al. Effect of adrenalectomy on the slimming activity of liposome-carried oleoyl-estrone in the rat. Int J Obes 22 (1998) 1225-1230
23. Grasa M.M., Cabot C., Esteve M., Yubero P., Masanés R.M., Blay M.T., et al. Daily oral oleoyl-estrone gavage induces a dose-dependent loss of fat in Wistar rats. Obes Res 9 (2001) 202-209
24. Sanchis D., Balada F., Grasa M.M., Virgili J., Peinado J., Monserrat C., et al. Oleoyl-estrone induces the loss of body fat in rats. Int J Obes 20 (1996) 588-594
25. Sanchis D., Balada F., Picó C., Grasa M.M., Virgili J., Farrerons C., et al. Rats receiving the slimming agent oleoyl-estrone in liposomes (Merlin-2) decrease food intake but maintain thermogenesis. Arch Physiol Biochem 105 (1997) 663-672
26. Sanchis D., Adán C., Ardévol A., Grasa M.M., Cabot C., Balada F., et al. Short-term treatment with oleoyl-oestrone in liposomes (Merlin-2) strongly reduces the expression of the ob gene in young rats. Biochem J 326 (1997) 357-360
27. Blay M., Peinado-Onsurbe J., Grasa M.M., Díaz-Silva M., Fernández-López J.A., Remesar X., et al. Effect of oral oleoyl-estrone treatment on plasma lipoproteins and tissue lipase activities of Zucker lean and obese female rats. Int J Obes 26 (2002) 618-626
28. Cabot C., Grasa M.M., Massanés R.M., de Matteis R., Cinti S., Fernández-López J.A., et al. Oleoyl-estrone does not have direct estrogenic effects on rats. Life Sci 69 (2001) 749-761
29. Serrano-Muñoz M., Grasa M., González-Martínez D., Cabot C., Fernández-López J.A., and Alemany M. Intestinal oleoyl-estrone esterase activity in the Wistar rat. J Endocrinol Invest 31 (2008) 125-131
30. Romero M.M., Vilà R., Fernández-López J.A., Esteve M., and Alemany M. Influence of oleoyl-estrone treatment on circulating testosterone. Role of 17ß-hydroxysteroid dehydrogenase isoenzymes. J Physiol Pharmacol 60 1 (2009) 181-190
31. Ferrer-Lorente R., García-Pelaez B., Gómez-Ollés S., Fernández-López J.A., Remesar X., and Alemany M. Effects of oral estrone on rat energy balance. Steroids 70 9 (2005) 667-672
32. Cabot C., González-Martínez D., Fernández-López J.A., and Alemany M. In the rat, estrone sulphate is the main serum metabolite of oral oleoyl-estrone. J Endocrinol Invest 30 (2007) 376-381
33. Adán C., Cabot C., Vilà R., Grasa M.M., Masanés R.M., Esteve M., et al. Oleoyl-estrone treatment affects the ponderostat setting differently in lean and obese Zucker rats. Int J Obes 23 (1999) 366-373
34. Cabot C., Grasa M.M., Estruch J., Fernández-López J.A., Remesar X., and Alemany M. Zucker obese rats are insensitive to the CRH-increasing effect of oleoyl-estrone. Brain Res Bull 46 (1998) 529-534
35. Adán C., Grasa M.M., Cabot C., Esteve M., Vilà R., Masanés R.M., et al. Short-term treatment with estrone oleate in liposomes (Merlin-2) does not affect the expression of the ob gene in Zucker obese rats. Mol Cell Biochem 197 (1999) 109-115
36. Grasa M.M., Cabot C., Adán C., Sanchis D., Balada F., Estruch J., et al. Effect of oleoyl-estrone administration on corticosterone binding to tissues of lean and obese Zucker rats. J Steroid Biochem Mol Biol 66 (1998) 165-169
37. Serrano-Muñoz M., Fernández-López J.A., Alemany M., and Grasa M.M. Oleoyl-estrone increases the availability of glucocorticoids in liver but limits its effects on phosphoenolpyruvate carboxykinase. 12th international congress on hormonal steroids and hormones and cancer. Athens (2006) p. 125, 273-4
38. Grasa M.M., Serrano M., Fernández-López J.A., and Alemany M. Corticosterone inhibits the lipid-mobilizing effects of oleoyl-estrone in adrenalectomized rats. Endocrinology 148 (2007) 4056-4063
39. Ferrer-Lorente R., Cabot C., Fernández-López J.A., Remesar X., and Alemany M. Effects of oleoyl-estrone with dexfenfluramine, sibutramine or phentermine on overweight rats. Eur J Pharmacol 513 (2005) 243-248
40. Grasa M.M., Cabot C., Fernández-López J.A., Remesar X., and Alemany M. Modulation of corticosterone availability to white adipose tissue of lean and obese Zucker rats by corticosteroid-binding globulin. Horm Metabol Res 33 (2001) 407-411
41. 2. Proc Nat Acad Sci USA 102 (2005) 6213-6218
42. Chung S.Y., Son G.H., Park S.H., Park E.Y., Lee K.H., Geum D.H., et al. Differential adaptive responses to chronic stress of maternally stresses male mice offspring. Endocrinology 146 (2005) 3202-3210
43. Vytasek R.A. A sensitive fluorometric assay for the determination of DNA. Anal Biochem 120 (1982) 43-248
44. Rat Genome Sequencing Project Consortium. Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature 428 (2004) 493-521
45. Romero M.M., Grasa M.M., Esteve M., Fernández-López J.A., and Alemany M. Semiquantitative RT-PCR measurement of gene expression in rat tissues including a correction for varying cell size and number. Nutr Metab 4 (2007) 26
46. Tomlinson J.W., Walker E.A., Bujalska I.J., Draper N., Lavery G.G., et al. 11β-hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response. Endocrine Rev 25 (2004) 831-866
47. Cabot C., Grasa M.M., Fernández-López J.A., Remesar X., and Alemany M. Effect of oleoyl-estrone treatment on the expression of β1-β2- and β3-adrenoceptors in rat adipose tissue. Mol Cell Biochem 221 (2001) 109-115
48. Russell J.C., Proctor S.D., Kelly S.E., and Brindley D.N. Pair feeding-mediated changes in metabolism: stress response and pathophysiology in insulin-resistant, atherosclerosis-prone JCR:LA-cp rats. Am J Physiol 294 (2008) E1078-E1087
49. Brock B.J., and Waterman M.R. Biochemical differences between rat and human cytochrome P450c17 support the different steroidogenic needs of these two species. Biochemistry 38 (1999) 1598-1606
50. Landschulz K.T., Pathak R.K., Rigotti A., Krieger M., and Hobbs H.H. Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat. J Clin Invest 98 (1996) 984-995
51. Grasa M.M., Esteve M., Massanés R.M., Yubero P., Blay M., et al. Oral gavage of oleoyl-estrone has a stronger effect on body weight in male Zucker obese rats than in female. Diabetes Obes Metab 3 (2001) 203-208
52. Tomlinson J.W., and Stewart P.M. The functional consequences of 11β-hydroxysteroid dehydrogenase expression in adipose tissue. Horm Metabol Res 34 (2002) 746-751
53. Sandeep T.C., Andrew R., Homer N.Z.M., Andrews R.C., Smith K., and Walker B.R. Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11β-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone. Diabetes 54 (2005) 872-879
54. Alléra A., and Wildt L. Glucocorticoid-recognizing and -effector sites in rat liver plasma membrane kinetics of corticosterone uptake by isolated membrane vesicles-I. Binding and transport. J Steroid Biochem Mol Biol 42 (1992) 737-756
55. Carlstedt-Duke J., Gustafsson J.A., Gustafsson S.A., and Wrange O. Interactions of corticosterone, 5α-dihydrocorticosterone and dexamethasone with proteins in rat liver cytosol. Eur J Biochem 73 (1977) 231-238
56. Morrill G.A., O'Connell M.E., Kostellow A.B., and Levine W.G. Effect of long-term administration of Δ9-tetrahydrocannabinol on hepatic mixed-function oxidase systems in the rat. Pharmacology 30 (1985) 20-24
57. Salas A., Esteve M., Grasa M.M., and Remesar X. Rats treated with oleoyl-oestrone maintain glucidic homeostasis: comparisons with a pair-fed model. Br J Nutr 94 (2005) 738-745
58. Seckl J.R., Morton N.M., Chapman K.E., and Walker B.R. Glucocorticoids and 11β-hydroxysteroid dehydrogenase in adipose tissue. Rec Progr Horm Res 59 (2004) 359-393
59. Duclos M., Pereira P.M., Barat P., Gatta B., and Roger P. Increased cortisol bioavailability, abdominal obesity, and the metabolic syndrome in obese women. Obes Res 13 (2005) 1157-1166
60. Vierhapper H., Nowotny P., and Waldhäusl W. Production rates of cortisol in obesity. Obes Res 12 (2004) 1421-1425